Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2018 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces November Conference Participation

SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus...
October 02, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces Oral Presentation at 2018 AASLD

SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus...
August 28, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences to Present at Upcoming Investor Conferences

SAN FRANCISCO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), today announced that the company will be participating in the following upcoming investor conferences in...
August 08, 2018 16:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces Second Quarter 2018 Financial Results

- ABI-H0731 Phase 2a Clinical Trials Actively Enrolling Patients; Initial Data Continues to be Anticipated in H1 2019 - Strong Balance Sheet Provides Significant Runway SAN FRANCISCO and...
July 25, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H0731 for the Treatment of Hepatitis B Virus Infection

INDIANAPOLIS and SAN FRANCISCO, July 25, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
July 16, 2018 16:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

INDIANAPOLIS and SAN FRANCISCO, July 16, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) (“Assembly”), today announced the closing of its previously announced underwritten public...
July 11, 2018 19:29 ET | Source: Assembly Biosciences

Assembly Biosciences Announces Pricing of $144 Million Offering of Common Stock

INDIANAPOLIS and SAN FRANCISCO, July 11, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) (“Assembly”), today announced the pricing of an underwritten public offering of 4,000,000...
July 10, 2018 16:01 ET | Source: Assembly Biosciences

Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock

INDIANAPOLIS and SAN FRANCISCO, July 10, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) (“Assembly”), today announced that it intends to offer and sell, subject to market and...
July 09, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection

Key aim is to demonstrate that core inhibitor therapy combined with standard of care antivirals can offer curative potential for HBV INDIANAPOLIS and SAN FRANCISCO, July 09, 2018 (GLOBE...
June 13, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences to Host Research and Development Day on Wednesday, June 20, 2018

INDIANAPOLIS and SAN FRANCISCO, June 13, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral...